Reported Reactions

Devices › System, test, human chorionic gonadotropin

Device brand name · System test human chorionic gonadotropin

Alinity i Total B-hCG Reagent Kit: medical device reports filed with FDA

262 reports name it, 2020–2026. Manufacturer given most often on reports: Abbott Ireland Diagnostics Division. Product code DHA.

262
device reports naming the brand
0% of all MAUDE reports · about 41 a year
74
reports, 12 months to August 2026
52 in the 12 months before
98.1%
classified as malfunction
95.7% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

262 medical device reports received by FDA name the brand "Alinity i Total B-hCG Reagent Kit" (system test human chorionic gonadotropin); the manufacturer given most often on reports is Abbott Ireland Diagnostics Division; received from February 2020 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

74 reports arrived in the 12 months to August 2026, up 42% from 52 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.1%) and injury (1.9%); across all system, test, human chorionic gonadotropin reports (product code DHA) death is recorded in 0% and malfunction in 95.7%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are false positive result (86.6%), false negative result (10.3%) and high test results (1.5%). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0510Sep 2021: 2Oct 2021: 2Nov 2021: 4Dec 2021: 02022Jan 2022: 2Feb 2022: 2Mar 2022: 4Apr 2022: 7May 2022: 2Jun 2022: 4Jul 2022: 4Aug 2022: 1Sep 2022: 2Oct 2022: 0Nov 2022: 6Dec 2022: 32023Jan 2023: 0Feb 2023: 1Mar 2023: 2Apr 2023: 5May 2023: 3Jun 2023: 3Jul 2023: 4Aug 2023: 6Sep 2023: 5Oct 2023: 5Nov 2023: 3Dec 2023: 62024Jan 2024: 4Feb 2024: 6Mar 2024: 5Apr 2024: 6May 2024: 5Jun 2024: 5Jul 2024: 5Aug 2024: 5Sep 2024: 7Oct 2024: 2Nov 2024: 4Dec 2024: 52025Jan 2025: 2Feb 2025: 2Mar 2025: 5Apr 2025: 6May 2025: 3Jun 2025: 8Jul 2025: 3Aug 2025: 5Sep 2025: 4Oct 2025: 9Nov 2025: 5Dec 2025: 102026Jan 2026: 3Feb 2026: 4Mar 2026: 5Apr 2026: 3May 2026: 9Jun 2026: 5Jul 2026: 9Aug 2026: 8

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

031622020: 320202021: 1220212022: 3720222023: 4320232024: 5920242025: 6220252026: 462026

Event type and report source

Event type, as classified on the report

Death0%0
Injury1.9%5
Malfunction98.1%257
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%262
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 3,587 reports carrying product code DHA. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
False positive result22786.6%34.8%
False negative result2710.3%8%
High test results41.5%24.9%
Incorrect, inadequate or imprecise result or readings20.8%3%
Low test results10.4%18.4%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

In context

MeasureAlinity i Total B-hCG Reagent KitProduct code DHAAll MAUDE reports
Reports2623,58726,136,888
Share of that pool—7.3%0%
Classified as death, per 1,000 reports009
Classified as injury1.9%2.8%36.2%
Classified as malfunction98.1%95.7%62.3%
Filed by the manufacturer100%99.4%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DHA

BrandReportsLatest 12 monthsClassified as death
ARCHITECT TOTAL B-hCG689510%
Architect Total B-Hcg Reagent Kit31000%
Unicel Dxi 800 Access Immunoassay System3,13300%
cobas 6000 e601 module902850%
Access 2 Immunoassay System4,71900%
Analytical E Module77200%
Elecsys 2010 Rack65700%
Cobas E411 Rack System36700.3%
Dimension Clinical Chemistry System1,89500.2%
Cobas E411 Disk System28500%
Architect I2000sr Analyzer1,78500.1%
Architect I2000 Analyzer38600%
Elecsys 2010 Disk26000%
Architect I1000sr Analyzer31000.3%
Immulite 200044600%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Alinity i Total B-hCG Reagent Kit reports

How many FDA reports name Alinity i Total B-hCG Reagent Kit?

262 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 74 in the latest 12 months.

What kinds of events are reported?

malfunction (98.1%) and injury (1.9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

false positive result (86.6%), false negative result (10.3%), high test results (1.5%), incorrect, inadequate or imprecise result or readings (0.8%) and low test results (0.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Alinity i Total B-hCG Reagent Kit was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.